CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Cancer and Genetics

ConsultantLive.com.
 

Complementary Therapies in Multiple Sclerosis: Why Mind-Set Is Everything

By Lasse Skovgaard, MA, MA (Ed.) | October 31, 2012
Lasse Skovgaard is a Researcher and PhD candidate in the Department of Public Health Research at the University of Copenhagen in Denmark and at The National Research Center in Complementary and Alternative Medicine at the University of Tromsø, Norway.

Many patients with MS use complementary-alternative medicine (CAM) on their own behalf along with traditional treatments—with or without their physician’s knowledge and cooperation.
 

What happens when CAM and traditional treatments are combined systematically into an integrated treatment approach? A 6-year project sponsored by the Danish MS Society tested the feasibility of an organized collaboration between a “traditional” doctor and CAM practitioners to investigate various outcomes (eg, symptoms and quality-of-life) for patients with MS.1
 

(MORE: Sex Ratio of Multiple Sclerosis)

The project revealed some interesting predictors of positive response to integrated treatment that had as much to do with the patients’ characteristics as with the success of the collaboration between various practitioners. Here, Lasse Skovgaard describes the study and its implications for care of patients with this disease.


Please describe the project?

Our 6-year research project—The MS Treatment Team Project—started in 2004. At that time, interest in CAM had been increasing among the members of the Danish MS Society. A survey showed that half of our members used CAM regularly—often in combination with conventional treatments.
 

At that time, little was known about possible benefits and challenges of combining conventional and CAM treatments for people with MS. Therefore we initiated the MS Treatment Team Project as a pioneer project with the aim of gaining more knowledge within this field. We established an integrative team of practitioners that included 5 conventional practitioners and 5 CAM practitioners; these 10 worked together to offer integrated courses of treatment to 200 people with MS. A group of 150 people with MS received only conventional treatment at another MS hospital and constituted a comparison group.


The project took place at one of the Danish MS hospitals. It ended in 2010, but it continues to inspire the ongoing development of rehabilitation program. The goals of the project were to investigate the collaboration process and to assess outcomes over 18 months from different methodological angles.


What alternatives therapies were used?
We included the 5 CAM modalities most commonly used by people with MS in Denmark. They were acupuncture, homeopathy, reflexology, craniosacral therapy, and nutritional therapy. The practitioners who administered these therapies were appointed by their professional organizations and all had experience treating people with MS.
 

What were the key findings?
From the quantitative perspective we found no significant differences in the overall development of self-reported symptom burden between the 2 groups. However, there was a statistically significant improvement in quality of life among those individuals who participated in the dual approach to therapy. The difference in quality of life lay in the areas of emotional well-being and thinking and fatigue.1 An explorative interview study showed that the participants in the dual approach group obtained very different types of outcomes—from no outcomes at all to long-term positive outcomes with physical symptoms and also with mental and emotional aspects.  An important outcome for many of the participants was the acquisition of tools to support their own ongoing assessment and regulation of interventions used and thereby their active participation in the course of treatment.2
 

Were there any predictors of positive response?
Participants who experienced long-term positive outcomes were characterized by a process-oriented perception of treatment mechanisms. They seemed more likely to take the next step, and to participate actively in assessing whether the interventions used were successful. They engaged in a mental and physical learning process, accumulating their experiences and using them in an ongoing manner. Among those who experienced long-term positive outcomes, we saw that a neutral or negative outcome could also be a part of their learning process and could thereby indirectly lead them to self-initiate new interventions. It turned out to be very much a question of mind-set.
 

Would you comment about the challenges care providers faced in trying to collaborate?
Collaboration was a challenge for 10 practitioners with very different backgrounds. A neurologist and a homeopathic physician have very different perceptions of such basic concepts as disease, symptoms, health, and science. It took a long time to achieve mutual understandings, but the process was fruitful for all practitioners.3
 

The team did not succeed in creating quite the interdisciplinary effort we had hoped for. However, it did achieve many interdisciplinary goals and jointly the 10 practitioners developed an integrated treatment model for rehabilitation of people with MS, which is quite an achievement.4
 

Does this study offer any general insights into CAM?
In Denmark – as in many Western countries – CAM has become increasingly popular over the last 20 years. The conventional health care system has generally met this development with unconcern. I believe that there is a lack of critical awareness about possible inconveniences and risks connected with use of CAM treatments—and a lack of awareness about their possible benefits. These benefits often need to be perceived—and researched—in different ways than conventional medical treatments, not least because the goals of CAM treatments and conventional medical treatments often differ. The former seeks to strengthen the whole organism and support the healing process; the latter is used to alleviate a specific symptom.   
 

What lessons does your study offer physicians who treat patients with MS?
We found that there are many possible benefits of interdisciplinary collaboration. We showed that by collaborating, conventional health care providers and CAM practitioners achieved a broad frame of understanding, which turned out to be very beneficial with regard to meeting the individual patient.
 

This project shed some light on the potential of an integrated and holistic approach to MS therapy. It pointed out the importance of the patient’s own efforts as well as the need for accommodating the complexity and individuality of the disease. New research projects have been initiated as a result.
 

References
1.  Bjerre L, Henningsen L, Skovgaard L, et al.  Self-reported changes in quality of life among people with multiple sclerosis who have participated in treatments based on collaboration between conventional healthcare providers and CAM practitioners. 2011. European J Integrative Med. 2011; 3: e271-e279
2. Skovgaard L, Launsø L, Pederson IK, et al. Combination treatment of people with multiple sclerosis based on collaboration between conventional healthcare providers and alternative practitioners—patient perspectives on outcomes. J Complement Integr Med. 2011;8:1-31.
3. Skovgaard L, Bjerre L, Haahr N, Launsø L. Types of collaboration between conventional and alternative practitioners – results from a research project at a Danish MS center. International Journal of Integrated Care. Volume 10, December 2010: 1-16
4.  Skovgaard L, Bjerre L, Haahr N et al. An investigation of multidisciplinary complex health care interventions – steps towards an integrative treatment model in the rehabilitation of people with multiple sclerosis. BMC Complementary and Alternative Medicine. Published online 23 April 2012.

 

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

MS primary care

Multiple Sclerosis: Role of Physical Therapy in Disease-Related Mobility Deficits

Simplified Testing for Cognitive Function in Multiple Sclerosis

Guidance for Treating Pediatric Multiple Sclerosis With Grown-Up Medications

Multiple Sclerosis: What Triggers Exacerbations?

Multiple Sclerosis: 10 Things Primary Care Providers Need to Know Now

The Importance of Bone Health in Multiple Sclerosis

Disease Modifying Therapies: Do They Modify Short- and Long-Term in Multiple Sclerosis?

Pregnancy, Breast Feeding—and Risk of Relapse in Multiple Sclerosis

Multiple Sclerosis and Epstein-Barr Virus: Is there a Connection?

The Genetics of Multiple Sclerosis: 4 Key Points

Venous Thromboembolism and Multiple Sclerosis

In Multiple Sclerosis, Motivational Interviewing Can Improve Exercise Experience

Smoking and Multiple Sclerosis

Complementary Therapies in Multiple Sclerosis: Why Mind-Set Is Everything

Wellness Program Improves Self-Efficacy in Multiple Sclerosis

Multiple Sclerosis and the Primary Care Physician’s Key Role

Intrathecal Methotrexate: A Treatment Option for Patients with Progressive Multiple Sclerosis?

Angioplasty Affords Symptom Relief for Patients With Multiple Sclerosis

Sex Ratio of Multiple Sclerosis





CancerNetwork on Facebook


 
RELATED CONTENT

New Therapeutic Target, MDM4, Found in Cutaneous Melanoma
July 24, 2012
Study Finds Different Treatment Responses Between BRCA2- and BRCA1-Mutated Ovarian Cancers
ONCOLOGY,  October 11, 2011
Screening Identifies Mechanisms of Drug Resistance to PI3K Inhibitors
ONCOLOGY,  September 27, 2011
Novel DNA-Silencing Function of BRCA1 Discovered
ONCOLOGY,  September 7, 2011
Role for PTEN in DNA Damage Removal and Prevention of Non-Melanoma Skin Cancer
July 28, 2011
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • A 49-Year-Old Woman Develops Thickened and Bound-Down Skin
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Preventing Exposure to Hazardous Drugs
  • Conflicts of Interest in Medicine: What About Ties to Payers?
  • Planning Treatment for Women With Recurrent Epithelial Ovarian Cancer
  • Rising PSA Level in a 46-Year-Old Man
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Cancer And Genetics
Evidence on Cancer And Genetics
Guidelines on Cancer And Genetics
Patient Education on Cancer And Genetics
Clinical Trials on Cancer And Genetics
Practical Articles on Cancer And Genetics
Research and Reviews on Cancer And Genetics
All "Cancer And Genetics" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy